Dr. Katy Peters, MD
Claim this profileDuke University School of Medicine
Studies Brain Cancer
Studies Melanoma
1 reported clinical trial
1 drug studied
Area of expertise
1Brain Cancer
Stage III
Stage IV
2Melanoma
Stage III
Stage IV
Affiliated Hospitals
Duke University School Of Medicine
More about Katy Peters, MD
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Katy Peters, MD has experience with
- ST101
Breakdown of trials Katy Peters, MD has run
Brain Cancer
Melanoma
Brain Tumor
Prostate Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katy Peters, MD specialize in?
Katy Peters, MD focuses on Brain Cancer and Melanoma. In particular, much of their work with Brain Cancer has involved Stage III patients, or patients who are Stage IV.
Is Katy Peters, MD currently recruiting for clinical trials?
No, Katy Peters, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Katy Peters, MD has studied deeply?
Yes, Katy Peters, MD has studied treatments such as ST101.
What is the best way to schedule an appointment with Katy Peters, MD?
Apply for one of the trials that Katy Peters, MD is conducting.
What is the office address of Katy Peters, MD?
The office of Katy Peters, MD is located at: Duke University School of Medicine, Durham, North Carolina 27708 United States. This is the address for their practice at the Duke University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.